GlassScriptPhysician profile
Abigail Randall
NPI 1790237683
$1,717.57
in general payments reported to CMS, 2019-2025
26 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $610 · 2022: $414 · 2023: $264 · 2024: $262 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $492.37 | 2021-2024 | Lifevest |
| Abiomed | $116.26 | 2021-2022 | |
| Noven Therapeutics, LLC | $103.50 | 2024-2025 | Xelstrym, Secuado |
| Janssen Pharmaceuticals, INC | $100.75 | 2021-2024 | Spravato |
| Nuwellis, INC. | $67.89 | 2021-2022 | |
| Pfizer INC. | $64.85 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $60.76 | 2025 | Austedo Xr |
| Ethicon US, LLC | $60.36 | 2023 | Vistaseal, Prolene, Ethicon |
| Edwards Lifesciences Corporation | $59.89 | 2021-2022 | |
| Axsome Therapeutics, INC. | $53.18 | 2025 | Auvelity |
| Cerus Corporation | $50.05 | 2024 | Intercept Blood System For Platelets |
| Abbott Laboratories | $47.18 | 2021-2022 | |
| Chiesi USA, INC. | $46.15 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.99 | 2024-2025 | Trintellix |
| Pacira Pharmaceuticals Incorporated | $44.22 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $43.19 | 2022 | |
| Atricure, INC. | $41.72 | 2021-2022 | |
| Amgen INC. | $32.17 | 2022 | |
| Alkermes, INC. | $29.60 | 2024 | Aristada, Lybalvi |
| Angiodynamics, INC. | $27.18 | 2022 | |
| Baxter Healthcare | $24.52 | 2023 | Coseal |
| Bolton Medical INC | $24.10 | 2024 | Treo Abdominal Stent-Graft System |
| La Jolla Pharmaceutical Company | $23.90 | 2023 | Giapreza |
| Potrero Medical, INC. | $23.65 | 2023 | |
| Haemonetics Corporation | $19.37 | 2022 | |
| Werfen USA LLC | $15.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Randall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.